Literature DB >> 32412420

Toward a Risk-Utility Data Governance Framework for Research Using Genomic and Phenotypic Data in Safe Havens: Multifaceted Review.

Kerina Jones1, Helen Daniels1, Sharon Heys1, Arron Lacey1, David V Ford1.   

Abstract

BACKGROUND: Research using genomic data opens up new insights into health and disease. Being able to use the data in association with health and administrative record data held in safe havens can multiply the benefits. However, there is much discussion about the use of genomic data with perceptions of particular challenges in doing so safely and effectively.
OBJECTIVE: This study aimed to work toward a risk-utility data governance framework for research using genomic and phenotypic data in an anonymized form for research in safe havens.
METHODS: We carried out a multifaceted review drawing upon data governance arrangements in published research, case studies of organizations working with genomic and phenotypic data, public views and expectations, and example studies using genomic and phenotypic data in combination. The findings were contextualized against a backdrop of legislative and regulatory requirements and used to create recommendations.
RESULTS: We proposed recommendations toward a risk-utility model with a flexible suite of controls to safeguard privacy and retain data utility for research. These were presented as overarching principles aligned to the core elements in the data sharing framework produced by the Global Alliance for Genomics and Health and as practical control measures distilled from published literature and case studies of operational safe havens to be applied as required at a project-specific level.
CONCLUSIONS: The recommendations presented can be used to contribute toward a proportionate data governance framework to promote the safe, socially acceptable use of genomic and phenotypic data in safe havens. They do not purport to eradicate risk but propose case-by-case assessment with transparency and accountability. If the risks are adequately understood and mitigated, there should be no reason that linked genomic and phenotypic data should not be used in an anonymized form for research in safe havens. ©Kerina Jones, Helen Daniels, Sharon Heys, Arron Lacey, David V Ford. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 15.05.2020.

Entities:  

Keywords:  data governance; data safe havens; genomic data

Year:  2020        PMID: 32412420     DOI: 10.2196/16346

Source DB:  PubMed          Journal:  J Med Internet Res        ISSN: 1438-8871            Impact factor:   5.428


  3 in total

Review 1.  The Value of Routinely Collected Data in Evaluating Home Assessment and Modification Interventions to Prevent Falls in Older People: Systematic Literature Review.

Authors:  Helen Daniels; Joe Hollinghurst; Richard Fry; Andrew Clegg; Sarah Hillcoat-Nallétamby; Silviya Nikolova; Sarah E Rodgers; Neil Williams; Ashley Akbari
Journal:  JMIR Aging       Date:  2021-04-23

2.  Public involvement & engagement in the work of a data safe haven: a case study of the SAIL Databank.

Authors:  Kerina H Jones; Sharon Heys; Rachel Thompson; Lynsey Cross; David Ford
Journal:  Int J Popul Data Sci       Date:  2020-08-24

3.  Digital Mental Health Challenges and the Horizon Ahead for Solutions.

Authors:  Luke Balcombe; Diego De Leo
Journal:  JMIR Ment Health       Date:  2021-03-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.